Related Content
Search Google Scholar for:
|
|
Science 27 November 1992:
Vol. 258. no. 5087, pp. 1485 - 1488
DOI: 10.1126/science.1359646
|
|
Articles
Science, Vol 258, Issue 5087, 1485-1488
Copyright © 1992 by American Association for the Advancement of Science
Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector
S Chatterjee,
PR Johnson,
and
KK Wong Jr
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Rockville, MD 20852.
An adeno-associated virus vector encoding an antisense RNA was used to transduce stable intracellular resistance to human immunodeficiency virus-1 (HIV-1) in human hemopoietic and non-hemopoietic cell lines. The antisense targets are present in all HIV-1 transcripts and include the TAR sequence, which is critical for transcription and virus replication, and the polyadenylation signal. Cell lines expressing antisense RNA showed up to 95 percent inhibition of gene expression directed by the HIV-1 long terminal repeat and greater than 99 percent reduction in infectious HIV-1 production, with no detectable cellular toxicity. Because of their efficient transcription and inability to recombine with HIV-1, adeno-associated virus vectors represent a promising form of anti-retroviral gene therapy.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice.
- L. Santat, H. Paz, C. Wong, L. Li, J. Macer, S. Forman, K. K. Wong, and S. Chatterjee (2005)
PNAS
102, 11053-11058
| Abstract »
| Full Text »
| PDF »
- Use of Transgenic HLA A*0201/Kb and HHD II Mice To Evaluate Frequency of Cytomegalovirus IE1-Derived Peptide Usage in Eliciting Human CD8 Cytokine Response.
- G. Gallez-Hawkins, M. C. Villacres, X. Li, M. C. Sanborn, N. A. Lomeli, and J. A. Zaia (2003)
J. Virol.
77, 4457-4462
| Abstract »
| Full Text »
| PDF »
- Gene therapy for HIV.
- A M L Lever (2001)
Sex Transm Inf
77, 93-96
| Full Text »
| PDF »
- Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.
- X. Tang, D. Mohuczy, Y. C. Zhang, B. Kimura, S. M. Galli, and M. I. Phillips (1999)
Am J Physiol Heart Circ Physiol
277, H2392-H2399
| Abstract »
| Full Text »
| PDF »
- Transduction of Primitive Human Marrow and Cord Blood-Derived Hematopoietic Progenitor Cells With Adeno-Associated Virus Vectors.
- S. Chatterjee, W. Li, C. A. Wong, G. Fisher-Adams, D. Lu, M. Guha, J. A. Macer, S. J. Forman, and K.K. Wong Jr (1999)
Blood
93, 1882-1894
| Abstract »
| Full Text »
| PDF »
- Is Gene Therapy for Hypertension Possible?.
- M. I. Phillips (1999)
Hypertension
33, 8-13
| Full Text »
| PDF »
- Comparative Analyses of Intracellularly Expressed Antisense RNAs as Inhibitors of Human Immunodeficiency Virus Type 1 Replication.
- G. Veres, U. Junker, J. Baker, C. Barske, C. Kalfoglou, H. Ilves, S. Escaich, H. Kaneshima, and E. Bohnlein (1998)
J. Virol.
72, 1894-1901
| Abstract »
| Full Text »
| PDF »
- Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals.
- U. Ranga, C. Woffendin, S. Verma, L. Xu, C. H. June, D. K. Bishop, and G. J. Nabel (1998)
PNAS
95, 1201-1206
| Abstract »
| Full Text »
| PDF »
- Gene Therapy for Infectious Diseases.
- B. A. Bunnell and R. A. Morgan (1998)
Clin. Microbiol. Rev.
11, 42-56
| Abstract »
| Full Text »
| PDF »
- Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
- B. S. Schnierle, J. Stitz, V. Bosch, F. Nocken, H. Merget-Millitzer, M. Engelstadter, R. Kurth, B. Groner, and K. Cichutek (1997)
PNAS
94, 8640-8645
| Abstract »
| Full Text »
| PDF »
- Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer.
- Y. Lu, V. Planelles, X. Li, C. Palaniappan, B. Day, P. Challita-Eid, R. Amado, D. Stephens, D. B. Kohn, A. Bakker, et al. (1997)
J. Biol. Chem.
272, 14523-14531
| Abstract »
| Full Text »
| PDF »
- Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 2. The Bedside.
- B. L. Maria, C. D. Medina, K. B.N. Hoang, and M. Ian Phillips (1997)
J Child Neurol
12, 77-84
| Abstract »
| PDF »
- Antisense Inhibition and Adeno-Associated Viral Vector Delivery for Reducing Hypertension.
- M. I. Phillips (1997)
Hypertension
29, 177-187
| Abstract »
| Full Text »
| PDF »
- Present status and future prospects for HIV therapies.
- M. Johnston and D. Hoth (1993)
Science
260, 1286-1293
| Abstract »
| PDF »
- The basic science of gene therapy.
- R. Mulligan (1993)
Science
260, 926-932
| Abstract »
| PDF »
- USING A VIRUS TO FIGHT HIV INFECTION.
- (1992)
Journal Watch (General)
1992, 7
| Full Text »
|
|
